Kinase-inhibitors for iodine-refractory differentiated thyroid cancer: still far from a structured therapeutic algorithm
Vincenzo Marotta, Maria Grazia Chiofalo, Francesca Di Gennaro, Antonio Daponte, Fabio Sandomenico, Paolo Vallone, Luciana Costigliola, Gerardo Botti, Franco Ionna, Luciano Pezzullo
Topics & Concepts
LenvatinibSorafenibMedicineRefractory (planetary science)OncologyThyroid cancerPlaceboInternal medicineClinical trialIodineCancerPharmacologyPathologyBiologyHepatocellular carcinomaChemistryAstrobiologyOrganic chemistryAlternative medicineThyroid Cancer Diagnosis and Treatment